Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324089 · ClinicalTrials.gov registry record · NA
Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01324089 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants.
The verdict
NCT01324089, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
There is some evidence that when resveratrol (a substance which is found in red grapes, peanuts and chocolate) is combined with Piperine (a substance found in pepper) it is more effective in fighting cancer. The purpose of this study is to see if resveratrol in combination with piperine is more effective than taking resveratrol alone. Since investigators don't know what dose of piperine to use in combination with resveratrol, two different doses of piperine will be studied. Twenty-four participants, equal numbers of males and females, will receive a single dose of resveratrol (2.5 grams) without piperine, resveratrol (2.5 grams) with piperine (5 mg), or resveratrol (2.5 grams) with piperine (25 mg).
Interventions
- DIETARY_SUPPLEMENT Resveratrol
- DIETARY_SUPPLEMENT Resveratrol 2.5 grams x 1 dose and Piperine 5 mg x 1 dose
- DIETARY_SUPPLEMENT Resveratrol 2.5 grams x 1 dose and Piperine 25 mg x 1 dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324089
The ClinicalTrials.gov registry entry for NCT01324089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Resveratrol is the first listed.
NCT01324089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324089 about?
NCT01324089 is a clinical study titled "Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol". There is some evidence that when resveratrol (a substance which is found in red grapes, peanuts and chocolate) is combined with Piperine (a substance found in pepper) it is more effective in fighting cancer. The purpose of this study is to see if resveratrol in combination with piperine is more effe...
What is the current status of trial NCT01324089?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2011-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01324089?
The interventions under investigation include: Resveratrol (DIETARY_SUPPLEMENT), Resveratrol 2.5 grams x 1 dose and Piperine 5 mg x 1 dose (DIETARY_SUPPLEMENT), Resveratrol 2.5 grams x 1 dose and Piperine 25 mg x 1 dose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01324089?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.